Evidence map›Paper›PMID 18768795›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2008

Highly efficient transient gene expression and gene targeting in primate embryonic stem cells with helper-dependent adenoviral vectors.

Keiichiro Suzuki, Kaoru Mitsui, Emi Aizawa, Kouichi Hasegawa, Eihachiro Kawase, Toshiyuki Yamagishi, Yoshihiko Shimizu, Hirofumi Suemori, Norio Nakatsuji, Kohnosuke Mitani

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 108 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Application of iPSC to Modelling of Respiratory Diseases.Advances in experimental medicine and biology · 2020
    Review
  7. Article
  8. Bi-allelic Homology-Directed Repair with Helper-Dependent Adenoviruses.Molecular therapy. Methods & clinical development · 2019
    Article
  9. Article
  10. Review
  11. Article
  12. Production of CRISPR/Cas9-Mediated Self-Cleaving Helper-Dependent Adenoviruses.Molecular therapy. Methods & clinical development · 2019
    Article
  13. CRISPR-Cas9 Genome Editing for Treatment of Atherogenic Dyslipidemia.Arteriosclerosis, thrombosis, and vascular biology · 2018
    Review
  14. Article
  15. Genome editing: a robust technology for human stem cells.Cellular and molecular life sciences : CMLS · 2017
    Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Keiichiro SuzukiDivision of Gene Therapy, Research Center for Genomic Medicine, Saitama Medical University, Hidaka, Saitama 350-1241, Japan.
Kaoru Mitsui
Emi Aizawa
Kouichi Hasegawa
Eihachiro Kawase
Toshiyuki Yamagishi
Yoshihiko Shimizu
Hirofumi Suemori
Norio Nakatsuji
Kohnosuke Mitani
Center for Genomic Science · ITFrontier Medical College · PKSaitama Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human embryonic stem (hES) cells are regarded as a potentially unlimited source of cellular materials for regenerative medicine. For biological studies and clinical applications using primate ES cells, the development of a general strategy to obtain efficient gene delivery and genetic manipulation, especially gene targeting via homologous recombination (HR), would be of paramount importance. However, unlike mouse ES (mES) cells, efficient strategies for transient gene delivery and HR in hES cells have not been established. Here, we report that helper-dependent adenoviral vectors (HDAdVs) were able to transfer genes in hES and cynomolgus monkey (Macaca fasicularis) ES (cES) cells efficiently. Without losing the undifferentiated state of the ES cells, transient gene transfer efficiency was approximately 100%. Using HDAdVs with homology arms, approximately one out of 10 chromosomal integrations of the vector was via HR, whereas the rate was only approximately 1% with other gene delivery methods. Furthermore, in combination with negative selection, approximately 45% of chromosomal integrations of the vector were targeted integrations, indicating that HDAdVs would be a powerful tool for genetic manipulation in hES cells and potentially in other types of human stem cells, such as induced pluripotent stem (iPS) cells.

Indexed as

Gene Transfer TechniquesAdenoviridaeAnimalsCell LineEmbryonic Stem CellsGene ExpressionGene TargetingGenetic VectorsHumansHypoxanthine PhosphoribosyltransferaseMacaca fascicularisMiceHypoxanthine Phosphoribosyltransferase

Identifiers

PMID18768795
PMCPMC2544531
OpenAlexW2129833491

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.